1. Holstege CP, Isom GE, Kirk MA. Cyanide and hydrogen sulfide. In : Nelson LS, Goldfrank LR, editors. Goldfrank's toxicologic emergencies. 9th ed. NewYork: McGraw-Hill Medical;2011. p. 1712–1724.
3. Sauer SW, Keim ME. Hydroxocobalamin: improved public health readiness for cyanide disasters. Ann Emerg Med. 2001; 37:635–641.
Article
4. Fortin JL, Giocanti JP, Ruttimann M, Kowalski JJ. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol (Phila). 2006; 44:Suppl 1. 37–44.
Article
5. Guidotti T. Acute cyanide poisoning in prehospital care: new challenges, new tools for intervention. Prehosp Disaster Med. 2006; 21:s40–s48.
Article
6. Borron SW, Baud FJ. Antidotes for acute cyanide poisoning. Curr Pharm Biotechnol. 2012; 13:1940–1948.
Article
7. Sather JE, Tantawy H. Toxins. Anesthesiol Clin. 2006; 24:647–670.
Article
8. Mitchell BL, Bhandari RK, Bebarta VS, Rockwood GA, Boss GR, Logue BA. Toxicokinetic profiles of α-ketoglutarate cyanohydrin, a cyanide detoxification product, following exposure to potassium cyanide. Toxicol Lett. 2013; 222:83–89.
Article
9. Baud FJ. Cyanide: critical issues in diagnosis and treatment. Hum Exp Toxicol. 2007; 26:191–201.
Article
10. Ellenhorn MJ, Barceloux DG. Ellenhorn's medical toxicology. 2nd ed. Baltimore: Williams & Wilkins;1997.
11. Baud FJ, Borron SW, Megarbane B, Trout H, Lapostolle F, Vicaut E, Debray M, Bismuth C. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med. 2002; 30:2044–2050.
Article
12. Baud FJ, Barriot P, Toffis V, Riou B, Vicaut E, Lecarpentier Y, Bourdon R, Astier A, Bismuth C. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med. 1991; 325:1761–1766.
Article
13. Baud FJ, Borron SW, Bavoux E, Astier A, Hoffman JR. Relation between plasma lactate and blood cyanide concentrations in acute cyanide poisoning. BMJ. 1996; 312:26–27.
Article
14. Eckstein M, Maniscalco PM. Focus on smoke inhalation: the most common cause of acute cyanide poisoning. Prehosp Disaster Med. 2006; 21:s49–s55.
15. Vanden Hoek TL, Morrison LJ, Shuster M, Donnino M, Sinz E, Lavonas EJ, Jeejeebhoy FM, Gabrielli A. Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010; 122:18 Suppl 3. S829–S861.
16. Hung YM, Hung SY, Olson KR, Chou KJ, Lin SL, Chung HM, Tung CN, Chang JC. Yam bean seed poisoning mimicking cyanide intoxication. Intern Med J. 2007; 37:130–132.
Article
17. Hall AH, Dart R, Bogdan G. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? Ann Emerg Med. 2007; 49:806–813.
Article
18. Klimmek R, Krettek C, Szinicz L, Eyer P, Weger N. Effects and biotransformation of 4-dimethylaminophenol in man and dog. Arch Toxicol. 1983; 53:275–288.
Article
19. Kerger H, Dodidou P, Passani-Kruppa D, Gruttner J, Birmelin M, Volz A, Waschke KF. Excessive methaemoglobinaemia and multi-organ failure following 4-DMAP antidote therapy. Resuscitation. 2005; 66:231–235.
Article
20. Satpute RM, Hariharakrishnan J, Bhattacharya R. Alpha-ketoglutarate and N-acetyl cysteine protect PC12 cells from cyanide-induced cytotoxicity and altered energy metabolism. Neurotoxicology. 2008; 29:170–178.
Article
21. Satpute RM, Hariharakrishnan J, Bhattacharya R. Effect of alpha-ketoglutarate and N-acetyl cysteine on cyanide-induced oxidative stress mediated cell death in PC12 cells. Toxicol Ind Health. 2010; 26:297–308.
Article
22. Mittal G, Singh T, Kumar N, Bhatnagar A, Tripathi RP, Tulsawani R, Vijayaraghavan R, Bhattacharya R. Radiolabeling and dose fixation study of oral alpha-ketoglutarate as a cyanide antidote in healthy human volunteers. Clin Toxicol (Phila). 2010; 48:509–515.
Article
23. Broderick KE, Potluri P, Zhuang S, Scheffler IE, Sharma VS, Pilz RB, Boss GR. Cyanide detoxification by the cobalamin precursor cobinamide. Exp Biol Med (Maywood). 2006; 231:641–649.
Article
24. Broderick KE, Balasubramanian M, Chan A, Potluri P, Feala J, Belke DD, McCulloch A, Sharma VS, Pilz RB, Bigby TD, Boss GR. The cobalamin precursor cobinamide detoxifies nitroprusside-generated cyanide. Exp Biol Med (Maywood). 2007; 232:789–798.
25. Chan A, Balasubramanian M, Blackledge W, Mohammad OM, Alvarez L, Boss GR, Bigby TD. Cobinamide is superior to other treatments in a mouse model of cyanide poisoning. Clin Toxicol (Phila). 2010; 48:709–717.
Article
26. Niknahad H, Ghelichkhani E. Antagonism of cyanide poisoning by dihydroxyacetone. Toxicol Lett. 2002; 132:95–100.
Article
27. Niknahad H, O'Brien PJ. Antidotal effect of dihydroxyacetone against cyanide toxicity in vivo. Toxicol Appl Pharmacol. 1996; 138:186–191.
28. Vick JA, Von Bredow JD. Effectiveness of intramuscularly administered cyanide antidotes on methemoglobin formation and survival. J Appl Toxicol. 1996; 16:509–516.
Article
29. Bhattacharya R, Jeevaratnam K, Raza SK, Das Gupta S. Protection against cyanide poisoning by the co-administration of sodium nitrite and hydroxylamine in rats. Hum Exp Toxicol. 1993; 12:33–36.
Article
30. Brenner M, Kim JG, Lee J, Mahon SB, Lemor D, Ahdout R, Boss GR, Blackledge W, Jann L, Nagasawa HT, Patterson SE. Sulfanegen sodium treatment in a rabbit model of sub-lethal cyanide toxicity. Toxicol Appl Pharmacol. 2010; 248:269–276.
Article
31. Zottola MA, Beigel K, Soni SD, Lawrence R. Disulfides as cyanide antidotes: evidence for a new in vivo oxidative pathway for cyanide detoxification. Chem Res Toxicol. 2009; 22:1948–1953.
Article